These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 24334432)

  • 61. Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillation.
    Alli O; Doshi S; Kar S; Reddy V; Sievert H; Mullin C; Swarup V; Whisenant B; Holmes D
    J Am Coll Cardiol; 2013 Apr; 61(17):1790-8. PubMed ID: 23500276
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prevalence and prognostic significance of device-detected subclinical atrial fibrillation in patients with heart failure and reduced ejection fraction.
    Zakeri R; Morgan JM; Phillips P; Kitt S; Ng GA; McComb JM; Williams S; Wright DJ; Gill JS; Seed A; Witte KK; Cowie MR;
    Int J Cardiol; 2020 Aug; 312():64-70. PubMed ID: 32169346
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Characteristics and outcomes of atrial fibrillation patients with or without specific symptoms: results from the PREFER in AF registry.
    Bakhai A; Darius H; De Caterina R; Smart A; Le Heuzey JY; Schilling RJ; Zamorano JL; Shah M; Bramlage P; Kirchhof P
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):299-305. PubMed ID: 29474715
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Detection of atrial fibrillation in patients with embolic stroke of undetermined source by prolonged monitoring with implantable loop recorders.
    Israel C; Kitsiou A; Kalyani M; Deelawar S; Ejangue LE; Rogalewski A; Hagemeister C; Minnerup J; Schäbitz WR
    Thromb Haemost; 2017 Oct; 117(10):1962-1969. PubMed ID: 28862284
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Stroke incidence in patients with cardiac implantable electronic devices remotely controlled with automatic alerts of atrial fibrillation. A sub-analysis of the HomeGuide study.
    Ricci RP; Vaccari D; Morichelli L; Zanotto G; Calò L; D'Onofrio A; Curnis A; Pisanò EC; Nangah R; Brieda M; Calzolari V; Melissano D; Rovai N; Gargaro A
    Int J Cardiol; 2016 Sep; 219():251-6. PubMed ID: 27340918
    [TBL] [Abstract][Full Text] [Related]  

  • 66. AF burden is important - fact or fiction?
    Boriani G; Diemberger I; Ziacchi M; Valzania C; Gardini B; Cimaglia P; Martignani C; Biffi M
    Int J Clin Pract; 2014 Apr; 68(4):444-52. PubMed ID: 24499075
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
    Ramlawi B; Abu Saleh WK; Edgerton J
    Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Improving thromboprophylaxis using atrial fibrillation diagnostic capabilities in implantable cardioverter-defibrillators: the multicentre Italian ANGELS of AF Project.
    Boriani G; Santini M; Lunati M; Gasparini M; Proclemer A; Landolina M; Padeletti L; Botto GL; Capucci A; Bianchi S; Biffi M; Ricci RP; Vimercati M; Grammatico A; Lip GY;
    Circ Cardiovasc Qual Outcomes; 2012 Mar; 5(2):182-8. PubMed ID: 22373906
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.
    Viles-Gonzalez JF; Kar S; Douglas P; Dukkipati S; Feldman T; Horton R; Holmes D; Reddy VY
    J Am Coll Cardiol; 2012 Mar; 59(10):923-9. PubMed ID: 22381428
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Impact of CHA
    Patel AA; Nelson WW; Schein J
    Clin Ther; 2016 Oct; 38(10):2196-2203.e5. PubMed ID: 27671867
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A Review.
    Hess PL; Healey JS; Granger CB; Connolly SJ; Ziegler PD; Alexander JH; Kowey PR; Ruff CT; Flaker G; Halperin JL; Hart RG; Lopes RD
    JAMA Cardiol; 2017 Mar; 2(3):324-331. PubMed ID: 28097334
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Atrial fibrillation diagnosed after stroke and dementia risk: cohort study of first-ever ischaemic stroke patients aged 65 or older.
    Krawczyk M; Fridman S; Cheng Y; Fang J; Saposnik G; Sposato LA
    Europace; 2019 Dec; 21(12):1793-1801. PubMed ID: 31531673
    [TBL] [Abstract][Full Text] [Related]  

  • 74. New atrial arrhythmia occurrence in single chamber implantable cardioverter defibrillator patients: A real-world investigation.
    Patel D; Rao A; Friedman PA; Deshmukh AJ; Lande J; Murphy JA; Brown ML; Lexcen DR; Wilkoff BL
    J Cardiovasc Electrophysiol; 2023 Feb; 34(2):438-444. PubMed ID: 36579406
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation.
    Giustozzi M; Agnelli G; Quattrocchi S; Acciarresi M; Alberti A; Caso V; Vedovati MC; Venti M; Paciaroni M
    Cerebrovasc Dis Extra; 2020; 10(2):44-49. PubMed ID: 32375143
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP
    Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570
    [TBL] [Abstract][Full Text] [Related]  

  • 77. SETAP: epidemiology and prevention of stroke and transient ischaemic attack in Czech patients with atrial fibrillation.
    Táborský M; Dušek L; Kautzner J; Vícha M; Aiglová R; Gloger V; Fedorco M; Duba J; Dušek L; Jarkovský J; Bezděková M; Skála T
    Europace; 2021 Apr; 23(4):539-547. PubMed ID: 33305813
    [TBL] [Abstract][Full Text] [Related]  

  • 78. "As Needed" nonvitamin K antagonist oral anticoagulants for infrequent atrial fibrillation episodes following atrial fibrillation ablation guided by diligent pulse monitoring: A feasibility study.
    Zado ES; Pammer M; Parham T; Lin D; Frankel DS; Dixit S; Marchlinski FE
    J Cardiovasc Electrophysiol; 2019 May; 30(5):631-638. PubMed ID: 30706975
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Temporal Association Between Episodes of Atrial Fibrillation and Risk of Ischemic Stroke.
    Singer DE; Ziegler PD; Koehler JL; Sarkar S; Passman RS
    JAMA Cardiol; 2021 Dec; 6(12):1364-1369. PubMed ID: 34586356
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation.
    Freeman JV; Shrader P; Pieper KS; Allen LA; Chan PS; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Naccarelli G; Reiffel JA; Singer DE; Go AS; Hylek EM; Steinberg BA; Peterson ED; Piccini JP
    Circ Arrhythm Electrophysiol; 2019 Dec; 12(12):e007612. PubMed ID: 31830822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.